DENVER—John D. Day, MD, from the Heart Institute at Intermountain Medical Center in Salt Lake City, revealed study findings to Cardiovascular Business News that atrial fibrillation (AF) ablation reduces the risk of stroke, mortality, Alzheimer’s disease (AD) and other forms of dementia. According to two new studies presented at the Heart Rhythm Society’s 31st annual scientific sessions, patients with AF treated with catheter ablation are less likely to develop Alzheimer’s disease or other forms of dementia and have a significantly reduced risk of stroke and death compared to patients with AF who are not treated with ablation.
Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.
Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.
